This Month in Psychopharmacology

Sleep EEG Brain Age Emerges as Possible Early Marker for Dementia Risk

Sleep disturbances are increasingly recognized as early indicators ...

Read More

Predicting Substance Use Behaviors with Machine Learning

In a recent study, researchers used a small set of variables and ma...

Read More

A Review of Evidence Reveals Minimal Support for Cannabinoids in Psychiatric Care

Cannabinoids are increasingly promoted and used for the treatment o...

Read More

Efficacy of the Neuroplastogen TSND-201 for the Treatment of PTSD

Posttraumatic stress disorder (PTSD) is a chronic and disabling psy...

Read More

Psilocybin Shows Greater Efficacy Than Nicotine Patches in Smoking Cessation Pilot Trial

More than two-thirds of U.S. smokers want to quit, but available tr...

Read More

Esketamine for Depressed Adolescents at Imminent Suicide Risk

Adolescents with depression have approximately a fivefold increased...

Read More

Clozapine After Failed Drug Trial in First-Episode Psychosis

Antipsychotic treatment algorithms in first-episode psychosis (FEP)...

Read More

From Awareness to Action: World Bipolar Day

World Bipolar Day is celebrated each year on March 30th. World Bipo...

Read More

FDA Expands Flibanserin Approval to Postmenopausal Women With Hypoactive Sexual Desire Disorder

The FDA has recently granted expanded approval for flibanserin to t...

Read More

Exercise Demonstrates Moderate Effects for Depression and Anxiety Across the Lifespan

A recent meta-meta-analysis examining the effects of structured exe...

Read More

Rethinking Mood Disorder Treatment with Immunometabolic Insights

While there are many stimulant and non-stimulant options targeting ...

Read More

Brain Awareness Week: March 16-22, 2026

Each March, the global community comes together to celebrate Brain ...

Read More